CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0. A total of 12 filers reported holding CLOVIS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,844,000 | -21.8% | 15,150,000 | 0.0% | 0.15% | -24.1% |
| Q2 2022 | $11,306,000 | -36.7% | 15,150,000 | -37.3% | 0.20% | -37.2% |
| Q1 2022 | $17,849,000 | -0.5% | 24,150,000 | 0.0% | 0.32% | +4.2% |
| Q4 2021 | $17,946,000 | -17.4% | 24,150,000 | 0.0% | 0.31% | -23.1% |
| Q3 2021 | $21,720,000 | -7.0% | 24,150,000 | +9.0% | 0.40% | -14.1% |
| Q2 2021 | $23,363,000 | -7.3% | 22,150,000 | 0.0% | 0.47% | -4.5% |
| Q1 2021 | $25,211,000 | +31.3% | 22,150,000 | 0.0% | 0.49% | +1.0% |
| Q4 2020 | $19,201,000 | -9.5% | 22,150,000 | 0.0% | 0.49% | -44.4% |
| Q3 2020 | $21,214,000 | – | 22,150,000 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 64,842,000 | $63,520,000 | 3.42% |
| QVT Financial LP | 15,000,000 | $14,638,000 | 1.79% |
| ARISTEIA CAPITAL, L.L.C. | 22,150,000 | $21,214,000 | 0.87% |
| WHITEBOX ADVISORS LLC | 9,300,000 | $8,861,000 | 0.37% |
| LMR Partners LLP | 13,099,000 | $12,793,000 | 0.26% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,100,000 | $5,842,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,500,000 | $1,442,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 2,025,000 | $1,982,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,968,000 | $1,875,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |